The Toronto Stock Exchange reports that Acerus Pharmaceuticals Corp. will be delisted from the TSX at the close on March 3, 2023. According to the TSX, the company has failed to meet its continued listing requirements. Acerus will remain suspended from trading.

For more information, see the TSX bulletin dated Jan. 26, 2023.